Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in NOMID/CINCA Syndrome
NCT00069329Phase 2Terminated
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Start
- Sep 2003
- Primary completion
- Apr 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in neonatal-onset multisystem inflammatory disease (NOMID), sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Started Sep 2003; status: terminated.
02
Drugs
anakinra
03
Conditions
neonatal-onset multisystem inflammatory disease (NOMID)
Beyond the preview
Go deeper on NCT00069329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069329.